Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ASC42 tablets for safety and efficacy in primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• ASC42

Snippet

Sponsor: Gannex Pharma Co., Ltd. | Conditions: Primary Biliary Cholangitis | Phase 2 | Status: COMPLETED